Antibody-Based Immunotoxins for Colorectal Cancer Therapy

Monoclonal antibodies (mAbs) are included among the treatment options for advanced colorectal cancer (CRC). However, while these mAbs effectively target cancer cells, they may have limited clinical activity. A strategy to improve their therapeutic potential is arming them with a toxic payload. Immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz, Laura, Ibáñez-Pérez, Raquel, Guerrero-Ochoa, Patricia, Lacadena, Javier, Anel, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615520/
https://www.ncbi.nlm.nih.gov/pubmed/34829955
http://dx.doi.org/10.3390/biomedicines9111729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615520/
https://www.ncbi.nlm.nih.gov/pubmed/34829955
http://dx.doi.org/10.3390/biomedicines9111729

Ejemplares similares